Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTHR.L Share News (STHR)

  • There is currently no data for STHR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up

Mon, 17th Dec 2018 08:34

(Sharecast News) - SThree: Numis upgrades to buy with a target price of 400p.Glanbia: Barclays reiterates equal weight with a target price of 1,680p.Reckitt Benckiser Group: Barclays reiterates equal weight with a target price of 6,500p.Reach: Barclays reiterates equal weight with a target price of 65p.Kaz Minerals: RBC Capital Markets reiterates sector perform with a target price of 590p.Gresham House: Jefferies initiates buy with a target price of 640p.Kaz minerals: Credit Suisse downgrades to underperform with a target price of of 400p.
More News

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.